Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$246.81 -0.76 (-0.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Jazz Pharmaceuticals (JAZZ) Gross Margin Growth (1y) (2011 - 2026)

Analysis

Jazz Pharmaceuticals (JAZZ) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 210.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1,034.00
10 Jazz Pharmaceuticals 15.60 Bn 13.98 Bn 1.09 Bn 149.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149.00
Mar 31, 2026 -89.00
Dec 31, 2025 -99.00
Sep 30, 2025 -87.00
Jun 30, 2025 -39.00
Mar 31, 2025 -106.00
Dec 31, 2024 -123.00
Sep 30, 2024 -7.00
Jun 30, 2024 -55.00
Mar 31, 2024 382.00
Dec 31, 2023 662.00
Sep 30, 2023 370.00
Jun 30, 2023 313.00
Mar 31, 2023 -24.00
Dec 31, 2022 -203.00
Sep 30, 2022 312.00
Jun 30, 2022 254.00
Mar 31, 2022 -755.00
Dec 31, 2021 -765.00
Sep 30, 2021 -967.00